Clinical Trials Directory

Trials / Conditions / Recurrent Endometrial Endometrioid Adenocarcinoma

Recurrent Endometrial Endometrioid Adenocarcinoma

8 registered clinical trials studyying Recurrent Endometrial Endometrioid Adenocarcinoma — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingTesting Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovaria
NCT05950464
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTesting the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate
NCT05538897
National Cancer Institute (NCI)Phase 1 / Phase 2
Active Not RecruitingTesting the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel a
NCT03914612
National Cancer Institute (NCI)Phase 3
Active Not RecruitingTazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer
NCT03348631
National Cancer Institute (NCI)Phase 2
Active Not RecruitingVSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer
NCT03120624
Mayo ClinicPhase 1
Active Not RecruitingA Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Re
NCT03008408
M.D. Anderson Cancer CenterPhase 2
CompletedEnzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid End
NCT02684227
M.D. Anderson Cancer CenterPhase 2
UnknownRadiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
NCT00492778
GOG FoundationPhase 2